T-cell immunoglobulin and mucin domain 3 (Tim-3) is a surface receptor expressed by T helper type 1 (Th1) effector CD4 T cells, which are critical for defence against intracellular pathogens and have been implicated in autoimmune disease. Previous studies showed that Tim-3 expression makes Th1 cells more susceptible to apoptosis and also marks functionally impaired T cells that arise due to chronic stimulation. However, other studies suggested that Tim-3-expressing Th1 cells do not always have these properties. To further define the relationship between Tim-3 and Th1 cell function, we analysed the characteristics of Th1 cells that expressed Tim-3 in response to brief stimulation in vitro or an acute viral infection in vivo. As expected, cultured CD4 T cells began expressing Tim-3 during Th1 differentiation and secondary stimulation generated Tim-3 À and Tim-3 + fractions that were separated and further analysed.
Summary
T-cell immunoglobulin and mucin domain 3 (Tim-3) is a surface receptor expressed by T helper type 1 (Th1) effector CD4 T cells, which are critical for defence against intracellular pathogens and have been implicated in autoimmune disease. Previous studies showed that Tim-3 expression makes Th1 cells more susceptible to apoptosis and also marks functionally impaired T cells that arise due to chronic stimulation. However, other studies suggested that Tim-3-expressing Th1 cells do not always have these properties. To further define the relationship between Tim-3 and Th1 cell function, we analysed the characteristics of Th1 cells that expressed Tim-3 in response to brief stimulation in vitro or an acute viral infection in vivo. As expected, cultured CD4 T cells began expressing Tim-3 during Th1 differentiation and secondary stimulation generated Tim-3 À and Tim-3 + fractions that were separated and further analysed.
When injected into naive mice, Tim-3 + cells down-regulated Tim-3 and survived equally well compared with Tim-3 -cells. Further, Tim-3 À and Tim-3 + Th1 cells had similar functional responses when transferred into naive mice that were subsequently infected with lymphocytic choriomeningitis virus (LCMV). Cultured Th1 cells that expressed Tim-3 following T-cell receptor stimulation had a greater capacity to express signature Th1 cytokines than their Tim-3 À counterparts and showed differential expression of genes that regulate CD4 T-cell function. Consistent with these findings, Tim-3 + Th1 cells generated in response to LCMV infection displayed augmented effector function relative to Tim-3 À cells.
Introduction
Tim-3 is a receptor expressed on the surface of immune cells that probably regulates both the innate and adaptive arms of the immune system. [1] [2] [3] This molecule is a member of the T-cell immunoglobulin and mucin domain (Tim) family, which includes three proteins in humans and four in mice. 4, 5 A hallmark feature of the Tims is their extracellular region, which consists of an N-terminal immunoglobulin variable region-like domain and a glycosylated mucin-like region. Tims also contain an intracellular cytoplasmic tail that varies in length between family members and can be phosphorylated by non-receptor tyrosine kinases. Through their immunoglobulin variable region-like domains, Tims are able to recognize the apoptotic cell marker phosphatidylserine and promote
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engulfment of apoptotic cells by phagocytes. [6] [7] [8] [9] Apart from this role, biochemical studies have suggested that the Tims regulate the function of T cells and other immune cell types by tuning intracellular signalling in either a positive or negative manner. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Tim-3 was first discovered by a screen for molecules that are selectively expressed on the surface of T helper type 1 (Th1) effector CD4 T cells (Th1 cells), 21 which are one of several effector cell types that can be formed by activated CD4 T cells during an immune response. 22, 23 The generation of effector CD4 T cells is initiated by interaction between naive CD4 T cells and antigen-presenting cells, which display peptide antigen-MHC II complexes that can engage the T-cell receptor (TCR) and also provide ligands for co-stimulatory receptors expressed by T cells. 24, 25 CD4 T cells that receive these signals will proliferate and differentiate into effector cells as directed by cytokines in the local environment. For Th1 cells, differentiation is driven by the cytokines interleukin-12 (IL-12), IL-27 and interferon-c (IFN-c), [26] [27] [28] which induce activation of signal transducer and activator of transcription family transcription factors. 29 These proteins, together with the transcription factor T-bet and other transcriptional regulators, establish the gene expression programme required for Th1 cell formation. 30 Th1 cells are critical for defence against pathogens that replicate within host cells, which include viruses and certain types of bacteria, fungi and protozoa. In addition, Th1 cell responses driven by recognition of self-antigens probably contribute to the pathogenesis of autoimmune disorders such as type 1 diabetes and multiple sclerosis. [31] [32] [33] Given these roles, it is important to elucidate pathways that regulate Th1 cell responses, which could unveil therapeutic approaches for manipulating their function.
Since its discovery, much effort has been made to understand how Tim-3 influences Th1 cell function. The glycan-binding protein Galectin-9 can recognize carbohydrate chains attached to Tim-3, and in vitro studies suggested that this interaction causes Tim-3-expressing Th1 cells to undergo apoptosis, so suppressing immune responses driven by these cells. 34, 35 However, other in vitro studies showed that Galectin-9 can induce apoptosis and augment cytokine production by CD4 T cells through Tim-3-independent pathways, 36 whereas other reports suggested that Galectin-9 influences CD4 T-cell function through multiple pathways. [37] [38] [39] Nonetheless, a number of in vivo studies using Tim-3 antibodies or other agents thought to block Tim-3-ligand interactions have provided support for the idea that Tim-3 acts in some way to restrain Th1-dependent immune responses. 3 In addition to Th1 cells, Tim-3 is expressed by functionally impaired, or exhausted, CD4 and CD8 T cells, 40 which are generated during immune responses to chronic infections [41] [42] [43] [44] or cancer. [45] [46] [47] These findings established that Tim-3 serves as a marker for exhausted T cells and also provided evidence that Tim-3 acts together with other molecules to enforce the exhausted state. In contrast, Tim-3 expression was associated with enhanced, rather than impaired, effector function by T cells from patients acutely infected with Mycobacterium tuberculosis. 48 These latter findings suggest that Tim-3 expression by T cells can be uncoupled from exhaustion and may, in some settings, be linked to augmented functionality.
In this study, we sought to further define the relationship between Tim-3 expression and CD4 T-cell function. To pursue this, we used in vitro and in vivo approaches to analyse the properties of Th1 cells that expressed Tim-3 following acute, rather than chronic, stimulation. We found that Tim-3 + Th1 cells generated in this manner were not more susceptible to apoptosis relative to those that did not express Tim-3. In addition, Tim-3 + Th1 cells generated by acute stimulation could mount robust responses to a viral infection, suggesting that these cells were not functionally impaired. Consistent with this conclusion, Th1 cells that expressed Tim-3 had augmented, rather than impaired, functional responses to acute stimulation in vitro or in vivo relative to Tim-3 À cells. Hence, Tim-3 expression by Th1 cells does not always correlate with increased apoptosis or functional impairment. In addition, these findings support the conclusion that Tim-3 expression by acutely stimulated Th1 cells can be a marker for cells with enhanced effector function.
Materials and methods

Mice
Naive mice were housed in a specific pathogen-free facility. For infection studies, mice were housed under animal biosafety level 2 conditions. Wild-type C57BL/6J (B6) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). SMARTA mice 49 expressing the Thy1.1 (CD90.1) variant of the surface protein Thy1 were provided by Dr Steven Varga (University of Iowa). All experimental procedures were approved by the University of Iowa Institutional Animal Care and Use Committee.
LCMV infection
The Armstrong strain of lymphocytic choriomeningitis virus (LCMV-Arm) was provided by Dr Steven Varga (University of Iowa) and was propagated using standard methods. Mice were injected intraperitoneally with 2 9 10 5 plaque-forming units of LCMV-Arm and analysed 8 days later.
Flow cytometric analysis
Splenocyte suspensions were generated by pushing the organ through a 70-lm wire mesh followed by depletion 
T-cell culture medium
All cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 1% L-glutamine, 50 units/ml penicillin, 50 lg/ml streptomycin and 50 lM b-mercaptoethanol. FBS was obtained from Atlanta Biologicals (Flowery Branch, GA) and the medium and other additives were obtained from Life Technologies (Carlsbad, CA).
In vitro CD4 T-cell differentiation and functional analysis
Spleen and lymph nodes were pooled and cell suspensions were prepared as described under flow cytometric analysis. Naive (CD62L + ) CD4 T cells were isolated using the mouse CD4 + CD62L + T Cell Isolation Kit II (Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions and resuspended in T-cell culture medium. To promote Th1 differentiation, medium was supplemented with 20 U/ml of IL-2, 4 ng/ml of IL-12 and 4 lg/ml of anti-IL-4. Both IL-2 and IL-12 were purchased from BD Biosciences; anti-IL-4 was purchased from eBioscience. Cells (5 9 10 5 /well) were added to 24-well plates coated with anti-CD3 and anti-CD28 (eBioscience). Wells were coated with antibodies by adding PBS containing anti-CD3 and anti-CD28 at 10 lg/ml followed by incubation and washing. Cells were cultured for 5 days at 37°in a 5% CO 2 incubator. To elicit effector cytokine production after Th1 differentiation, cells were harvested, washed, resuspended in T-cell medium supplemented with 20 U/ml of IL-2, and plated onto wells coated with anti-CD3. Cells were harvested 5-24 hr later for RNA isolation, collection of supernatant for ELISA, or intracellular cytokine analysis.
For intracellular staining of cytokines or Granzyme B, Th1 cells were incubated on wells coated with anti-CD3 for 12 hr at 37°in a 5% CO 2 incubator, after which GolgiPlug or GolgiStop (BD Biosciences) was added followed by a 5-hr incubation at 37°in a 5% CO 2 incubator. Cells were harvested, washed with stain buffer and stained for cell surface markers. After washing, cells were resuspended in Cytofix/Cytoperm (BD Biosciences) and incubated for 15 min at room temperature. Cells were washed with Perm/Wash (BD Biosciences) and resuspended in Perm/Wash containing fluorochrome-conjugated anticytokine or anti-Granzyme B antibodies. Cells were incubated for 20 min at 4°, washed with Perm/Wash and resuspended in stain buffer for analysis. For intracellular staining of T-bet, cells were cultured and processed as described above except cells were fixed and permeabilized using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience).
Microarray analysis
CD4 T cells were isolated and differentiated under Th1 conditions, harvested and restimulated on wells coated with anti-CD3 for 6 hr. Cells were harvested and incubated with fluorochrome-conjugated antibodies specific for CD4, Thy1.2 and Tim-3. After washing, CD4 + Thy.12 + cells were sorted into Tim-3 À and Tim-3 + fractions using a BD FACSAria (BD Bioscience). Recovered cells were resuspended in Trizol and stored at À80°. Cell samples from three independent sort purifications were collected and RNA was purified by standard methods. RNA concentrations were determined using a NanoDrop 1000 spectrophotometer and the integrity and purity of RNA was assessed using an Agilent 2100 bioanalyzer. Twenty-five nanograms of RNA was converted to single primer isothermally amplified cDNA using the WT-Ovation Pico RNA Amplification System, v1 (NuGEN Technologies, San Carlos, CA). (Table S1 ).
Adoptive transfer of SMARTA CD4 T cells
For adoptive transfer of naive cells, peripheral blood was collected from SMARTA mice and depleted of red blood cells using VitaLyse (BioE, St Paul, MN). Numbers of SMARTA cells in samples were calculated by multiplying total cell counts by the frequencies of SMARTA cells (defined as CD4 + Thy1.1 + and Vb8.3 TCR + ) as determined by flow cytometry. For adoptive transfer of Th1 cells, SMARTA cells were isolated from spleens and differentiated under Th1 conditions for two consecutive rounds. Dead cells were removed using the Dead Cell Removal Kit (Miltenyi Biotec) according to the manufacturer's instructions. Cells were resuspended in stain buffer and incubated for 20 min on ice with phycoerythrin-conjugated anti-Tim-3. Cells were washed and separated into Tim-3 À and Tim-3 + fractions using Anti-phycoerythrin Microbeads (Miltenyi Biotec) according to the manufacturer's instructions. Cells were suspended in saline and injected intravenously into host mice: 2 9 10 6 cells were injected into mice that were left uninfected and 7Á5 9 10 5 cells were injected into mice that were infected with LCMV-Arm 16 hr later. To analyse responses by naive SMARTA cells, 1 9 10 4 cells were injected intravenously into host mice, which were infected with LCMV-Arm 16 hr later.
Ex vivo stimulation and functional analysis of SMARTA cells
Splenocytes were resuspended in T-cell medium containing LCMV GP [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] peptide (1 lM) and either GolgiPlug or GolgiStop and then incubated for 5 hr at 37°in a 5% CO 2 incubator. Cells were harvested, washed and stained for cell surface markers. After washing, cells were suspended in Cytofix/Cytoperm (BD Biosciences) and incubated for 15 min at room temperature. Cells were then washed with Perm/Wash (BD Biosciences) and resuspended in Perm/Wash containing fluorochrome-conjugated anti-Granzyme B, anti-IFN-c, or anti-TNF. Cells were incubated for 20 min at 4°, washed with Perm/Wash and resuspended in stain buffer for flow cytometric analysis. For intracellular staining of T-bet, cells were cultured and processed as described above except cells were fixed and permeabilized using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience). For CD107a staining, anti-CD107a was added to cells along with LCMV GP [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] peptide and GolgiStop when cultures were initiated, and then cells were incubated for 5 hr at 37°in a 5% CO 2 incubator. Cells were then harvested, washed and stained for cell surface markers.
Statistical analysis
Data were analysed using the unpaired, two-tailed Student's t-test within PRISM (GraphPad Software, La Jolla, CA).
Results
Tim-3 + Th1 cells generated in vitro have augmented effector function
To analyse Tim-3 mRNA and protein expression during Th1 differentiation in vitro, naive CD4 T cells from B6 mice were cultured under the appropriate conditions and samples of cells were harvested on days 2, 3 and 5 of culture. A portion of cells was analysed immediately and the remainder were restimulated overnight through the TCR using an antibody specific for the CD3e subunit and then analysed. Expression of Tim-3 mRNA and protein was measured by quantitative RT-PCR (qRT-PCR) and flow cytometry, respectively (Fig. 1a,b ). Tim-3 mRNA levels in cells harvested on day 2 were similar to the baseline values of naive cells and increased only slightly in response to restimulation. Also, cells harvested on day 2 did not express Tim-3 protein either before or after restimulation. On day 3, the levels of Tim-3 mRNA and the frequencies of Tim-3 + cells were near baseline, but both increased in response to restimulation. For cells harvested on day 5, the levels of Tim-3 mRNA and the frequencies of Tim-3 Hence, as shown previously, 21, 52 these data confirm that CD4 T cells begin expressing Tim-3 upon Th1 differentiation. These results also show that Tim-3 expression is sharply up-regulated by differentiated cells in response to secondary TCR stimulation.
To characterize the functional properties of Tim-3 + Th1 cells, naive CD4 T cells were differentiated in culture, recovered and restimulated through the TCR to elicit expression of Tim-3 and the Th1 cytokines IFN-c and TNF. Tim-3 À and Tim-3 + cells were detected after TCR restimulation as expected (Fig. 1c) . These populations expressed the transcription factor T-bet and Granzyme B at similar levels (Fig. 1d ), indicating that both had undergone Th1 differentiation. However, the Tim-3 + fraction contained significantly higher frequencies of cells producing IFN-c or TNF, and more Tim-3 + cells expressed both IFN-c and TNF simultaneously (Fig. 1e,f) . These results show that Tim-3 expression by Th1 cells generated in vitro correlates with an augmented ability to produce Th1 cytokines. for genes associated with immune responses (data not shown). Among differentially expressed genes were those encoding cell surface proteins, secreted molecules and transcription factors with roles in the immune system ( Fig. 2b-d ).
We performed qRT-PCR analysis to verify some of the differences in gene expression identified by microarray analysis. Among the differentially expressed genes encoding cell surface proteins, Tim-3 mRNA levels were significantly higher in Tim-3 + cells as expected, whereas those encoding the surface proteins IFN-cR2 and SLAMF6 were expressed at lower levels (see Supplementary material, Fig. S1a ). Analysis of genes in the group encoding secreted factors confirmed that mRNAs encoding IL-10, CCL9 and Perforin were all expressed at significantly higher levels in Tim-3 + cells and that IL-2 RNA was significantly reduced (see Supplementary material, Fig. S1b ). Increased expression of IL-10 was also confirmed at the protein level (see Supplementary material, Fig. S1c ). Analysis of genes encoding transcription factors showed that mRNAs encoding B lymphocyte-induced maturation protein 1 (BLIMP-1; PRDM1) and inhibitor of differentiation 2 protein (ID2) were expressed at significantly higher levels in Tim-3 + cells, whereas those encoding ID3 and T-cell factor 7 (TCF7) were expressed at significantly lower levels (see Supplementary material, Fig. S1d ). Together, these data confirm that genes with key roles in the immune system are expressed at different levels in Tim-3 À and Tim-3 + Th1 cells, supporting the conclusion that Tim-3 + Th1 cells are functionally distinct from those that are Tim-3 À .
Tim-3 + Th1 cells persist following transfer into naive hosts
Cell culture studies showed that Tim-3 + Th1 cells undergo apoptosis when exposed to Galectin-9, implying that Tim-3 marks cells destined for apoptotic cell death. 34, 36 To explore the link between Tim-3 and apoptosis in vivo, we asked whether Tim-3 À and Tim-3 + Th1 cells showed differences in survival following adoptive transfer into host mice. To carry out these studies, we used CD4 T cells from SMARTA TCR-transgenic mice 49 expressing the Thy1.1 variant of the surface protein Thy1. SMARTA CD4 T cells (SMARTA cells) express a TCR specific for the GP 61-80 peptide from LCMV, which can be used to restimulate cells ex vivo. Thy1.1 expression allowed SMARTA cells to be distinguished from host CD4 T cells during analysis (see Fig. 4b ). SMARTA cells were isolated and differentiated under Th1 conditions for Tim-3 + Th1 cells can persist in vivo and have augmented function two successive rounds, which gave rise to roughly equal proportions of Tim-3 À and Tim-3 + cells (Fig. 3a) that expressed similar levels of T-bet and Granzyme B (Fig. 3b,c) . When restimulated in vitro through the TCR using anti-CD3, Tim-3 + SMARTA cells generated higher frequencies of IFN-c and TNF-producing cells compared with Tim-3 À cells (Fig. 3d-f) , again showing that Tim-3
can mark cells with a greater capacity to produce Th1 cytokines. SMARTA Th1 cells were separated into Tim-3 À and Tim-3 + subsets (Fig. 4a) . Immediately after separation, each population was injected into different host mice and spleens were harvested for analysis 7 days later. Similar frequencies and total numbers of SMARTA cells were detected in mice that received either Tim-3 À or Tim-3 + cells (Fig. 4b,c) . In addition, Tim-3 expression was downregulated by SMARTA cells that were Tim-3 + at the time of injection, although these cells still expressed more Tim-3 relative to those that were Tim-3 À before injection (Fig. 4d,e) .
We also evaluated functional responses by recovered SMARTA cells by culturing splenocytes in the presence of GP [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] peptide to stimulate cytokine production. Control cultures confirmed that cytokine expression required the addition of the peptide (data not shown). SMARTA cells from hosts that received Tim-3 + cells generated higher frequencies of IFN-c-producing cells compared with those from mice that received Tim-3 À cells, and had greater median fluorescence intensities (MFI) for IFN-c staining, indicating these cells expressed more IFN-c on a per cell basis (Fig. 4f,g ). SMARTA cells from mice that received either Tim-3 À or Tim-3 + cells generated similar frequencies of TNF-producing cells and no differences in the MFI for TNF staining were observed (Fig. 4h,i) . However, cells from hosts that received Tim-3 + cells generated higher frequencies of cells that produced both IFN-c and TNF (Fig. 4j,k) .
To Fig. S2a,b) . As expected, Tim-3 expression was down-regulated by SMARTA cells that were Tim-3 + before injection, although these still expressed more Tim-3 relative to cells that were Tim-3 À before injection (see (Fig. 5a,b) . Additionally, both populations of transferred cells generated similar frequencies of Tim-3-expressing cells (Fig. 5c,d) (Fig. 5e,f) . Also, ex vivo GP 61-80 peptide stimulation of splenocytes from mice given Tim-3 À or Tim-3 + cells generated similar frequencies of IFN-c-and TNF-producing cells and the MFI for staining were similar between the two groups (Fig. 5g,  h ). However, SMARTA cells from mice given Tim-3 + cells generated significantly greater MFI for IFN-c staining.
Regardless of the donor cell type, the frequencies of SMARTA cells able to produce both TNF and IFN-c simultaneously were similar (Fig. 5i,j) . We also analysed CD107a expression to measure degranulation by Th1 cells in response to peptide stimulation. SMARTA cells from mice given either Tim-3 À or Tim-3 + cells generated similar frequencies of CD107a + cells, but the MFI of cells from mice injected with Tim-3 + cells were significantly higher (see Supplementary material, Fig. S3a,b) . Hence, Tim-3 À and Tim-3 + SMARTA Th1 cells mount similar responses to an acute infection and both generate the expected effector cell subsets.
We next asked if Tim-3 + Th1 cells generated in response to LCMV-Arm infection showed augmented effector function, which would be predicted from our in vitro studies. SMARTA cells in LCMV-infected mice that initially received Tim-3 + Th1 cells were subdivided based on Tim-3 expression and cytokine production was analysed (Fig. 6a,b) . Significantly greater frequencies of IFN-c-and TNF-producing cells were detected in the Tim-3 + fraction of cells relative to the Tim-3 À subset.
Also, the MFI for IFN-c and TNF staining were significantly higher for Tim-3 + cells compared with those that were Tim-3 À . Analysis of CD107a expression produced the same pattern of results (see Supplementary material, Fig. S4a,b) . The frequencies of Tim-3 + cells that expressed IFN-c together with TNF were also significantly elevated (Fig. 6c,d 
Naive CD4 T cells responding to acute infection generate Tim-3 + Th1 cells with enhanced effector function
The experiments described above involved adoptive transfer of Th1 cells generated in vitro, but left unknown whether Tim À and Tim-3 + Th1 cells generated in vivo from naive cells have similar properties. To address this, naive SMARTA cells were injected into host mice, which were then infected with LCMV-Arm. Spleens from infected mice were harvested for analysis 8 days after infection. SMARTA cells were present at a relatively low frequency (~1Á6% of the total cells; Fig. 7a ) and~45% were Tim-3 + (Fig. 7b,c) . As observed in vitro, Tim-3 À and Tim-3 + SMARTA cells generated in response to LCMV infection expressed similar levels of T-bet and Granzyme B (Fig. 7d,e) , indicating that both subsets had differentiated into Th1 cells. Analysis of cytokine production in response to ex vivo stimulation with GP [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] peptide showed that the Tim-3 + subset of SMARTA cells contained significantly higher frequencies of IFN-c-and TNF-producing cells relative to the Tim-3 À fraction (Fig. 7f,g ). Also, the MFI generated by staining for IFN-c or TNF were significantly higher for the Tim-3 + subset (Fig. 7g) . Consistent with these results, the Tim-3 + fraction contained greater frequencies of cells that produced both IFN-c and TNF (Fig. 7h) . Also, the Tim-3 + subset contained significantly higher frequencies of CD107a + cells (Fig. 7i ). These results demonstrate that Tim-3 + Th1 cells generated in vivo in response to an acute infection have augmented Th1 effector function. 
Discussion
We used in vitro and in vivo models to define the characteristics of Tim-3 + Th1 cells responding to acute stimulation. Consistent with previous studies, 21, 52 CD4 T cells began expressing Tim-3 as they differentiated into Th1 effector cells. We further noted that Tim-3 expression by Th1 cells was strongly up-regulated by secondary As expected, we found that CD4 T cells undergoing Th1 differentiation begin expressing Tim-3 and our timecourse analysis suggested that Tim-3 mRNA and protein expression becomes increasingly permissive as Th1 differentiation progresses. Previous studies showed that Tim-3 expression is regulated by the Th1 transcription factor Tbet. 52 Interestingly, our data show that Tim-3 À and Tim-3 + Th1 cells generated in vitro or in vivo express T-bet at similar levels, suggesting that T-bet alone does not dictate Tim-3 expression levels. Consistent with this idea, additional mechanisms have been implicated in the regulation of Tim-3 expression, including IL-27-induced activation of the transcription factor NFIL3 and DNA methylation. 55, 56 Further, Tim-3 mRNA and protein levels were increased when Th1 cells were restimulated through TCR, suggesting that Tim-3 expression is regulated by transcription factors activated because of TCR signalling. Additionally, our global gene expression analysis suggested that Tim-3 + Th1 cells are distinct from their Tim-3 À counterparts and are more differentiated, which could facilitate Tim-3 expression. Evidence supporting the conclusion that Tim-3 + cells are more polarized toward a Th1 phenotype includes increased expression of mRNAs encoding the proteins BLIMP-1, ID2, CCR2, CXCR6, Granzyme A and Perforin and decreased expression of mRNAs encoding the proteins TCF-1/TCF-7, ID3, IL-2, IFN-cR2, and IL-6Ra, which are features associated with highly differentiated Th1 cells. 54, [57] [58] [59] [60] [61] The idea that Tim-3 + Th1 cells are more differentiated is also supported by our data showing that Tim-3 + Th1 cells have a greater capacity to produce IFN-c and TNF and to degranulate in response to TCR stimulation. Hence, in some circumstances Tim-3 expression may mark highly differentiated Th1 cells.
Following adoptive transfer into naive mice, Tim-3 + cells down-regulated Tim-3, suggesting that some form of stimulation is required to sustain surface Tim-3 expression in vivo. In accord with this, studies by others have shown that T cells responding to acute infections 48, 62 or exposed to chronic antigen and cytokine stimulation [41] [42] [43] [44] [45] [46] [47] express high levels of Tim-3. This conclusion is also supported by our data showing that Tim-3 is expressed by adoptively transferred naive CD4 T cells or Th1 cells responding to LCMV infection. These findings are in line with the idea that Tim-3 expression is regulated in part by TCR-induced signalling pathways as suggested by our in vitro studies.
The finding that Tim-3 À and Tim-3 + Th1 cells persisted equally well following transfer into naive hosts argues that the latter are not more susceptible to Galectin-9-dependent (or independent) pathways for apoptosis as was observed in cell culture studies. 21 In addition to Galectin-9, Tim-3 can also recognize phosphatidylserine and HMGB1 as ligands, 9, 63 but whether these factors induce apoptosis or have some other impact on T-cell function has not been established. Although Galectin-9 appears to be constitutively expressed in several organs including the spleen, 64, 65 it is possible that the levels of Galectin-9 expressed in naive mice are not sufficient to induce apoptosis through Tim-3. Studies by others have shown that Galectin-9 expression is up-regulated by inflammatory cytokines or viral infections. [66] [67] [68] [69] [70] [71] [72] [73] [74] Therefore, we also tested whether Tim-3 + Th1 cells were prone toward apoptosis in the context of acute LCMV infection, which induces a robust inflammatory response. Again, we found no evidence for Tim-3 + Th1 cells being more sensitive to apoptosis compared with Tim-3 À cells. Further, our data showed that Tim-3 À and Tim-3 + Th1 cells mount similar effector responses to LCMV infection, suggesting that Tim-3 + Th1 cells are not more susceptible to other potential mechanisms of functional suppression compared with Tim-3 À cells. This conclusion contrasts with that idea that Tim-3 expression invariably enforces inhibition on Th1 cells, as suggested by studies using agents to block Tim-3-ligand interactions. 3 Hence, in some contexts Tim-3 expression alone may not be sufficient to suppress or restrain Th1 cell function.
Our studies showed that Th1 cells expressing Tim-3 produce more effector cytokines in response to stimulation (relative to Tim-3 À cells) and may be more highly differentiated. Other studies demonstrated that exhausted T cells generated in response to chronic stimulation express high levels of Tim-3 [41] [42] [43] [44] [45] [46] [47] and provided evidence that Tim-3 enforces the functional impairment of T-cell exhaustion. Yet, in patients actively infected with M. tuberculosis, Tim-3 expression marks CD4 and CD8 T cells with a greater propensity to produce IFN-c, TNF and other effector molecules. 48 Likewise, tumour-infiltrating CD8 T cells expressing Tim-3 can have increased effector function compared with their Tim-3 À counterparts. 75, 76 Similar to these findings, our data demonstrated that, involving a combined total of seven mice. All bar graphs represent the mean and standard error of values pooled from two independent experiments involving a combined total of seven mice. **P < 0Á01; ***P < 0Á001; ****P < 0Á0001. after acute stimulation in vitro or in response to acute LCMV infection, Tim-3 expression by CD4 T cells was associated with enhanced effector function. These findings suggest that Tim-3 expression is not restricted to exhausted T cells and does not invariably promote functional impairment. One explanation for the differences between our findings and those involving exhausted T cells may be that the impact of Tim-3 on T-cell function is context-dependent and varies due to factors that are specific to acute or chronic stimulation. Nonetheless, our data support the conclusion that Tim-3 is expressed by CD4 T cells with augmented function that are generated in response to acute stimulation. Tim-3 has long been considered to be a negative regulator of T-cell function. Although not directly addressed by the results presented here, our data at least support the idea that Tim-3 can augment, rather than suppress, CD4 T-cell activation. This conclusion is consistent with studies demonstrating that Tim-3 enhances functional responses by CD8 T cells, mast cells and transformed dendritic cells. 12, 62, [77] [78] [79] In addition, molecular studies have provided evidence that Tim-3 can augment activation of signal transduction events induced by T-cell receptor engagement 18 and can increase the activity of the mTORC1 signalling pathway. 77 Hence, accumulating data suggest that, at least under some circumstances, Tim-3 can positively regulate immune cell responses.
Seminal studies of Tim-3 function demonstrated that treatment with anti-Tim-3 antibodies can reverse T-cell exhaustion caused by chronic antigen stimulation. 41, 44, 45 These findings were interpreted to signify that anti-Tim-3 antibodies interfered with interactions between Tim-3 and its ligands, so relieving Tim-3-mediated negative regulation. In light of evidence that Tim-3 can function as a positive regulator, an alternative interpretation is that anti-Tim-3 antibody treatment results in cross-linking of Tim-3, so inducing downstream signalling pathways that stimulate T-cell function. Such a mechanism would also explain data showing that in vitro stimulation of T cells in the presence of anti-Tim-3 antibodies promotes proliferation, differentiation and effector function. 41, 48, 77 
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